dc.contributor.author
Olivan Riera, Mireia
dc.contributor.author
Springer, Jochen
dc.contributor.author
Busquets Rius, Sílvia
dc.contributor.author
Tschirner, Anika
dc.contributor.author
Figueras, Maite
dc.contributor.author
Toledo Soler, Miriam
dc.contributor.author
Fontes de Oliveira, Cibely Cristine
dc.contributor.author
Genovese, Maria Inês
dc.contributor.author
Ventura da Silva, Paula
dc.contributor.author
Sette, Angelica
dc.contributor.author
López-Soriano, Francisco J.
dc.contributor.author
Anker, Stefan
dc.contributor.author
Argilés Huguet, Josep Ma.
dc.date.issued
2020-07-08T12:30:01Z
dc.date.issued
2020-07-08T12:30:01Z
dc.date.issued
2012-08-21
dc.date.issued
2020-07-08T12:30:01Z
dc.identifier
https://hdl.handle.net/2445/168103
dc.description.abstract
Background and aims: the aim of the present investigation was to examine the anti-wasting effects of theophylline (a methylxantine present in tea leaves) on a rat model of cancer cachexia. Methods: the in vitro effects of the nutraceuticals on proteolysis were examined on muscle cell cultures submitted to hyperthermia. Individual muscle weights, muscle gene expression, body composition and cardiac function were measured in rats bearing the Yoshida AH-130 ascites hepatoma, following theophylline treatment. Results: Theophylline treatment inhibited proteolysis in C2C12 cell line and resulted in an anti-proteolytic effect on muscle tissue (soleus and heart), which was associated with a decrease in circulating TNF-alpha levels and with a decreased proteolytic systems gene expression. Treatment with the nutraceutical also resulted in an improvement in body composition and cardiac function. Conclusion: Theophylline - alone or in combination with drugs - may be a candidate molecule for the treatment of cancer cachexia.
dc.format
application/pdf
dc.publisher
BioMed Central
dc.relation
Reproducció del document publicat a: https://doi.org/10.1186/1743-7075-9-76
dc.relation
Nutrition and Metabolism, 2012, vol. 9, num. 1, p. 76
dc.relation
https://doi.org/10.1186/1743-7075-9-76
dc.rights
cc-by (c) Olivan Riera, Mireia et al., 2012
dc.rights
http://creativecommons.org/licenses/by/3.0/es
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject
Ratolins (Animals de laboratori)
dc.subject
Mice (Laboratory animals)
dc.title
Theophylline is able to partially revert cachexia in tumour-bearing rats
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion